Polyethylene Glycol (PEGs & PEOs)

Tetraethyl heptane-1,7-diylbis(phosphonate).

Tetraethyl heptane-1,7-diylbis(phosphonate).

Tetraethyl octane-1,8-diylbis(phosphonate).

Tetraethyl octane-1,8-diylbis(phosphonate).

Tetraethyl octane-1,8-diylbis(phosphonate).

Tetraethylene glycol is a polymer consisting of ethylene glycol monomer units and two terminal hydroxyl groups. The hydroxyl groups can be reacted to further derivatize the compound. Ethylene glycol compounds have hydrophilic characteristics. The

Tetraethylene glycol is a polymer consisting of ethylene glycol monomer units and two terminal hydroxyl groups. The hydroxyl groups can be reacted to further derivatize the compound. Ethylene glycol compounds have hydrophilic characteristics. The

Thalidomide-Acid is a derivative of Thalidomide. It is commonly used as a precursor to PROTAC that hijacks cereblon as the E3 ubiquitin ligase component. Supplied with a carboxylic acid functional handle at a position known not to significantly

Thalidomide-Acid is a derivative of Thalidomide. It is commonly used as a precursor to PROTAC that hijacks cereblon as the E3 ubiquitin ligase component. Supplied with a carboxylic acid functional handle at a position known not to significantly

Thalidomide-Acid is a derivative of Thalidomide. It is commonly used as a precursor to PROTAC that hijacks cereblon as the E3 ubiquitin ligase component. Supplied with a carboxylic acid functional handle at a position known not to significantly

E3 ligase ligand-linker conjugate, Thalidomide-O-amido-PEG4-azide, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.

E3 ligase ligand-linker conjugate, Thalidomide-O-amido-PEG4-azide, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.